This inventor holds 46 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 3 EPO patents, primarily in Degradable Chelants. Top assignees: The Dow Chemical Company, Isotherapeutics Group LLC, Dow Global Technolgoies LLC. Active years: 1982-2021.
Location History:
- Freeport, TX (US) (1984)
- West Columbia, TX (US) (1999)
- Lake Jackson, TX (US) (1982 - 2021)
Company Filing History:
38 out of 7,680 
3 out of 3 
2 out of 4,797 
Years Active: 1982-2021
Areas of Expertise:
Title: **Druce K. Crump: Innovator in Radioactive Therapeutics**
Introduction
Druce K. Crump is a distinguished inventor based in Lake Jackson, Texas, known for his substantial contributions to the field of radioactive compositions and their therapeutic applications. With a remarkable portfolio of 46 patents, Crump has made significant strides in developing innovative solutions aimed at treating serious health conditions such as cancer and arthritis.
Latest Patents
Among Crump's latest advancements are his patents concerning radioactive compositions and methods for their therapeutic use. These inventions focus on pharmaceutically-acceptable compositions comprising radioactive metals, designed to combat various diseases in both animals and humans. His pioneering work in this domain showcases the potential of radioactive materials in modern medicine and highlights the integration of innovation into therapeutic practices.
Career Highlights
Crump has had an impressive career, with tenure at notable companies including The Dow Chemical Company and Isotherapeutics Group LLC. His experiences at these institutions have undoubtedly equipped him with the knowledge and skills necessary to drive advancements in his field. The combination of his extensive research and practical applications has resulted in impactful innovations that resonate within the healthcare community.
Collaborations
Throughout his career, Crump has collaborated with notable professionals including David A. Wilson and Jaime Simon. These partnerships exemplify the importance of teamwork and shared vision in the pursuit of groundbreaking discoveries. Together, they have fostered an environment conducive to innovation, significantly advancing therapeutic methods and compositions.
Conclusion
Druce K. Crump's commitment to innovation in the field of radioactive therapies underscores his role as a key inventor in the medical landscape. With his extensive patent portfolio and collaborative efforts, Crump continues to drive forward the boundaries of research and application, making a meaningful impact in the treatment of critical diseases. His work not only highlights the potential of radioactive substances in medicine but also inspires future innovations in therapeutic technology.